Left to right: AbCellera head of BD Kevin Heyries, CEO Carl Hansen, COO Véronique Lecault, head of corporate development Murray McCutcheon
AbCellera raises $105M in first major venture round as Covid-19 antibody nears clinic
Over its first decade of existence, AbCellera had many things: A new technology with sci-fi vibes, funding from the Bill & Melinda Gates Foundation, government …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
